Brief: Medicenna Announces Peer-Reviewed Publication Of Clinical Data From Phase 2B Trial Evaluating MDNA55
07/05/2021 14:07
May 7 (Reuters) - Medicenna Therapeutics Corp MDNA.TO :
* MEDICENNA ANNOUNCES THE PEER-REVIEWED PUBLICATION OF
CLINICAL
DATA FROM PHASE 2B TRIAL EVALUATING MDNA55 IN RECURRENT
GLIOBLASTOMA
Source text for Eikon: ID:nGNX1DGMNX
Further company coverage: MDNA.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results